Product image of Glucose Baxter (Glucose Monohydrate) supplied by GNH India

Glucose Baxter

Active Ingredient:
Glucose Monohydrate
Origin:
EU

Glucose Baxter (Glucose Monohydrate)

Glucose Baxter is an intravenous preparation containing glucose monohydrate as the active ingredient. It is supplied in a sterile solution form for parenteral administration, and is marketed in the European Union. The product provides a source of carbohydrate for patients requiring rapid glucose supplementation, such as during surgery or when oral intake is not possible. It is typically used under medical supervision and stored according to standard pharmaceutical guidelines.

Manufacturer / TM Owner

Baxter Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucose Baxter is used in clinical settings where rapid provision of glucose is required, such as during surgery, in intensive care units, or when patients cannot meet their carbohydrate needs orally.

  • Intravenous fluid therapy for patients unable to ingest carbohydrates orally.
  • Management of hypoglycemia in emergency or perioperative care.
  • Energy source during prolonged fasting or critical illness.
  • Support for metabolic needs during major surgery or trauma.
  • Dilution and addition to other IV solutions as a carbohydrate supplement when appropriate.

Side Effects

The safety profile of intravenous glucose reflects the expected physiological response to carbohydrate infusion.

Common

  • Transient increase in blood glucose levels.
  • Mild hyperosmolarity at the infusion site.
  • Temporary nausea or vomiting.
  • Local irritation or phlebitis at the catheter site.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Electrolyte imbalance, particularly hyponatremia.
  • Hypotension from rapid infusion.
  • Allergic reaction such as rash or anaphylaxis (rare).

Precautions & Warnings

When administering Glucose Baxter, healthcare professionals should observe several precautionary measures to ensure patient safety and optimal therapeutic effect.

  • Verify the patient’s baseline blood glucose level before infusion.
  • Adjust the infusion rate according to individual fluid and electrolyte status.
  • Continuously monitor for signs of hyperglycemia during and after administration.
  • Use aseptic technique to prevent contamination of the intravenous line.
  • Assess renal function, as impaired clearance may affect glucose handling.
  • Consider contraindications such as known hypersensitivity to glucose solutions.

Avoid Interactions

Glucose Baxter may interact with other medications or clinical conditions that influence carbohydrate metabolism or fluid balance.

Avoid

  • Co‑administration with high‑dose insulin without appropriate glucose monitoring.
  • Simultaneous infusion of additional hypertonic dextrose solutions that could cause excessive osmolar load.

Use with caution

  • Concurrent use of diuretics that may alter electrolyte balance.
  • Patients receiving corticosteroids, which can increase blood glucose levels.
  • Administration alongside drugs that affect renal function, such as nephrotoxic agents.

Frequently Asked Questions

Glucose Baxter provides a rapid source of glucose through intravenous infusion to support patients who cannot obtain carbohydrates orally or need immediate metabolic support.

The product is supplied as a sterile solution for intravenous infusion and should be administered by qualified healthcare personnel using standard IV techniques.

It is commonly used during surgery, in intensive care units, for treatment of acute hypoglycemia, and when patients are fasting or unable to tolerate oral intake.

Common side effects include a temporary rise in blood glucose, mild hyperosmolarity at the infusion site, nausea, vomiting, and local irritation or phlebitis.

Blood glucose should be measured before starting the infusion and periodically during treatment to detect hyperglycemia or hypoglycemia promptly.

Patients with diabetes may receive Glucose Baxter, but dosing and monitoring must be individualized and coordinated with their insulin or oral hypoglycemic regimen.

Renal function should be evaluated before infusion, and the rate or total volume may need adjustment to avoid fluid overload and electrolyte disturbances.

Concurrent high‑dose insulin can cause severe hypoglycemia if glucose infusion is insufficient; careful glucose monitoring and dose adjustment are required.

Use aseptic technique, ensure the IV line is primed correctly, and replace administration sets according to institutional infection‑control policies.

The solution should be stored at controlled room temperature, protected from light, and used before the expiration date indicated on the packaging.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.